XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 4 - Balance Sheet Components (Tables)
3 Months Ended
Mar. 31, 2024
Notes Tables  
Cash, Cash Equivalents and Investments [Table Text Block]
  

Amortized

  

Gross Unrealized

  

Estimated

  

Cash and

  

Short-Term

 
  

Cost

  

Gains

  

Losses

  

Fair Value

  

Cash Equivalents

  

Investments

 

March 31, 2024

                        

Cash at banks

 $4,078  $  $  $4,078  $4,078  $ 

Money market funds

  17,710         17,710   17,710    

U.S. Treasury securities

  14,886      (10)  14,876   4,947   9,929 

Total

 $36,674  $  $(10) $36,664  $26,735  $9,929 
  

Amortized

  

Gross Unrealized

  

Estimated

  

Cash and 

  

Short-Term

 
  

Cost

  

Gains

  

Losses

  

Fair Value

  

Cash Equivalents

  

Investments

 

December 31, 2023

                        

Cash at banks

 $3,352  $  $  $3,352  $3,352    

Money market funds

  31,403         31,403   31,403    

U.S. Treasury securities

  4,959      (1)  4,958      4,958 

Total

 $39,714  $  $(1) $39,713  $34,755  $4,958 
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
  

March 31, 2024

  

December 31, 2023

 
         

Prepaid clinical and manufacturing expenses

 $1,762  $984 

Unbilled revenue from government contracts

  

1,596

    
Prepaid insurance  933   258 
Prepaid rent  528   488 
Interest receivable  140   127 
Other  2,105   958 

Prepaid expenses and other current assets

 $7,064  $2,815 
Property, Plant and Equipment [Table Text Block]
  

March 31, 2024

  

December 31, 2023

 
         

Laboratory equipment

 $13,507  $13,448 

Office and computer equipment

  1,105   1,105 

Leasehold improvements

  3,998   3,985 

Construction in progress

  226   24 

Total property and equipment

  18,836   18,562 

Less: accumulated depreciation

  (7,734)  (6,831)

Property and equipment, net

 $11,102  $11,731 
Schedule of Finite-Lived Intangible Assets [Table Text Block]
  

March 31, 2024

  

December 31, 2023

 
         

Developed technology

 $5,000  $5,000 

Intellectual property

  80   80 

Total cost

  5,080   5,080 

Less: accumulated amortization

  (974)  (791)

Intangible assets, net

 $4,106  $4,289 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Year Ending December 31,

 

Amount

 

2024 (nine months remaining)

 $548 

2025

  732 

2026

  731 

2027

  731 

2028

  727 

Thereafter

  637 

Total

 $4,106 
Schedule of Accrued Liabilities [Table Text Block]
  

March 31, 2024

  

December 31, 2023

 
         

Accrued compensation

 $3,199  $4,576 

Accrued clinical and manufacturing expenses

  180   312 

Accrued professional and consulting services

  707   211 

Other liabilities, current portion

  894   535 

Total

 $4,980  $5,634